These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 19597472

  • 21. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST, Carew JS, Douglas L, Cleveland JL, Humphreys R, Houghton JA.
    Cancer Res; 2007 Jul 15; 67(14):6987-94. PubMed ID: 17638911
    [Abstract] [Full Text] [Related]

  • 22. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
    Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O.
    J Gene Med; 2007 Jun 15; 9(6):440-51. PubMed ID: 17410615
    [Abstract] [Full Text] [Related]

  • 23. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.
    Morales JC, Ruiz-Magaña MJ, Ruiz-Ruiz C.
    Mol Immunol; 2007 Apr 15; 44(10):2587-97. PubMed ID: 17257681
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
    VanOosten RL, Earel JK, Griffith TS.
    Cancer Gene Ther; 2006 Jun 15; 13(6):628-32. PubMed ID: 16456549
    [Abstract] [Full Text] [Related]

  • 25. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
    Inoue H, Shiraki K, Ohmori S, Sakai T, Deguchi M, Yamanaka T, Okano H, Nakano T.
    Int J Mol Med; 2002 May 15; 9(5):521-5. PubMed ID: 11956660
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL.
    Kaminskyy VO, Surova OV, Vaculova A, Zhivotovsky B.
    Carcinogenesis; 2011 Oct 15; 32(10):1450-8. PubMed ID: 21771726
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep 15; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 30. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.
    Carlisi D, Lauricella M, D'Anneo A, Emanuele S, Angileri L, Di Fazio P, Santulli A, Vento R, Tesoriere G.
    Eur J Cancer; 2009 Sep 15; 45(13):2425-38. PubMed ID: 19643600
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
    Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M.
    Hepatology; 2006 Mar 15; 43(3):425-34. PubMed ID: 16583461
    [Abstract] [Full Text] [Related]

  • 33. Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP.
    Venza I, Visalli M, Oteri R, Teti D, Venza M.
    Int Immunopharmacol; 2014 Aug 15; 21(2):439-46. PubMed ID: 24946096
    [Abstract] [Full Text] [Related]

  • 34. Significant inhibition of TRAIL-mediated fibroblast-like synovial cell apoptosis by IFN-gamma through JAK/STAT pathway by translational regulation.
    Tamai M, Kawakami A, Tanaka F, Miyashita T, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Huang M, Kamachi M, Ida H, Origuchi T, Eguchi K.
    J Lab Clin Med; 2006 Apr 15; 147(4):182-90. PubMed ID: 16581346
    [Abstract] [Full Text] [Related]

  • 35. Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapy-induced apoptosis by enhancing p53-dependent Bax activation.
    Häcker S, Karl S, Mader I, Cristofanon S, Schweitzer T, Krauss J, Rutkowski S, Debatin KM, Fulda S.
    Oncogene; 2011 May 12; 30(19):2275-81. PubMed ID: 21562496
    [Abstract] [Full Text] [Related]

  • 36. Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells.
    Fröhlich LF, Mrakovcic M, Smole C, Lahiri P, Zatloukal K.
    PLoS One; 2014 May 12; 9(3):e91558. PubMed ID: 24618889
    [Abstract] [Full Text] [Related]

  • 37. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V, Bodner B, Qin JZ, Nickoloff BJ.
    J Dermatol Sci; 2006 Jan 12; 41(1):31-41. PubMed ID: 16289694
    [Abstract] [Full Text] [Related]

  • 38. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK, Yu R, Deedigan L, Mohr A, Zwacka RM.
    Cancer Lett; 2012 Mar 28; 316(2):168-77. PubMed ID: 22104728
    [Abstract] [Full Text] [Related]

  • 39. Interferon-gamma and TRAIL in human breast tumor cells.
    Ruiz de Almodóvar C, López-Rivas A, Ruiz-Ruiz C.
    Vitam Horm; 2004 Mar 28; 67():291-318. PubMed ID: 15110183
    [Abstract] [Full Text] [Related]

  • 40. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.
    Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6401-9. PubMed ID: 14695141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.